108 will be in China's pharmaceutical arena!

For the pharmaceutical industry, 2021 is still an extremely extraordinary year
.

The development of the epidemic has changed from a violent storm at the beginning to a repeated one, and new virus mutants are frequently discovered

According to their corporate attributes, we divide them into Chinese pharmaceutical companies and multinational pharmaceutical companies
.

The Pharmaceutical Times team analyzed the stock price performance of multinational pharmaceutical companies not long ago.

Traditional pharmaceutical companies: to maintain the existing product market, but also to develop new growth paths

With the normalization of the centralized drug procurement and medical insurance negotiation system, the price of drugs is returning from inflated to reasonable
.

Traditional Chinese pharmaceutical companies are facing shrinking revenue from falling drug prices

Chinese biotech: the navigator of Chinese medicine in the next 20 years

If traditional pharmaceutical companies represent the first 20 years of Chinese pharmaceutical development, then Chinese biotech companies will lead the next 20 years of Chinese pharmaceutical development
.

Although Chinese biotech companies may not have products that are already on the market, and may not have a penny in revenue, they are more able to spot unmet needs in the market and more urgent clinical needs

A summary of BeiGene's listing in the three places[1] can be read from the company's prospectus.
The company's rapid development is inseparable from a high proportion of R&D investment.
The company has raised more than 70% of its funds for the development of clinical trials
.

Although the company has not achieved profitability during the three IPO reporting periods, the company is gradually growing with the advancement of the research and development pipeline

BeiGene R&D pipeline

Image source: BeiGene official website

In addition to obtaining products through self-research, biotech companies also obtain revenue from the corresponding market through external authorization
.

This also demonstrates the international competitiveness of the self-developed products of China's biotech companies

CXO: A force to be reckoned with

As a service provider for pharmaceutical research and development, CXO does not have its own products and generally obtains income by providing services to pharmaceutical companies
.

Therefore, it is not easy to be noticed by ordinary people

Epilogue

According to the market value on December 31, 2021, we found that multinational pharmaceutical companies topped the list with a market value of over one trillion RMB
.

Taking market value as a measure, only WuXi PharmaTech and Hengrui can barely get close to this echelon in China

References:

References:

[1] https://mp.
weixin.
qq.
com/s?src=11×tamp=1642000314&ver=3554&signature=IQhNhtm-wKEs6kRd7gQlb8be9ThEEQx*1fALwYYK82XRGBdcLbaOG8eYqA2afTraZDM3yzX1sHCrQ9QgPJfoFhPcadFZuVU-yvwH3X7E2JKXtAMXCXXBKJj7yRdrMQEq&new=1

[1] https://mp.
weixin.
qq.
com/s?src=11×tamp=1642000314&ver=3554&signature=IQhNhtm-wKEs6kRd7gQlb8be9ThEEQx*1fALwYYK82XRGBdcLbaOG8eYqA2afTraZDM3yzX1sHCrQ9QgPJfoFhPcadFZuVU-yvwH3X7E2JKXtAMXCXXBKJj7yRdrMQEq&new=1

[2] Five years have passed, has BeiGene completed the listing of the three major pharmaceutical companies in BeiGene? https://mp.
weixin.
qq.
com/s?src=11×tamp=1642004858&ver=3554&signature=FcTM0HfAgD2y4ft-o-vz0yVOvgPyauESOQ2YKuliDgH1OqOHlquLB2sWEGYj0CgAtq1PvRWozMHfiDLkiKTGxTV5pYIQpdazRyvdJe15g9zC5Xti7rwdez28V3N*xqUP&new=1

[2] Five years have passed, has BeiGene completed the listing of the three major pharmaceutical companies in BeiGene? https://mp.
weixin.
qq.
com/s?src=11×tamp=1642004858&ver=3554&signature=FcTM0HfAgD2y4ft-o-vz0yVOvgPyauESOQ2YKuliDgH1OqOHlquLB2sWEGYj0CgAtq1PvRWozMHfiDLkiKTGxTV5pYIQpdazRyvdJe15g9zC5Xti7rwdez28V3N*xqUP&new=1

[3] Copy PD-1? TIGIT has become a fragrant pastry in the sea, and Baekje and Junshi have gone to sea to form a group.
The first and second camps have been formed
.
Who is next in the country?

[3] Copy PD-1? TIGIT has become a fragrant pastry in the sea, and Baekje and Junshi have gone to sea to form a group.
The first and second camps have been formed
.
Who is next in the country?